Utilization of Autologous Hematopoietic Cell Transplantation Over Time in Multiple Myeloma: A Population-Based StudyNaseem Esteghamat, Theresa H.M. Keegan, Lori Muffly et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 8
Linking the Center for International Blood and Marrow Transplant Research Registry to the California Cancer Registry and California Hospital Patient Discharge DataTheresa H.M. Keegan, Lindsay M. Morton, Ann Brunson et al.|Transplantation and Cellular Therapy|2022Cited by 7
Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018Bryan Valcárcel, Lindsay M. Morton, Sara J. Schonfeld et al.|Transplantation and Cellular Therapy|2023Cited by 3
Cumulative incidence estimates for solid tumors after HCT in the CIBMTR and California Cancer RegistrySara J. Schonfeld, Lindsay M. Morton, Bryan Valcárcel et al.|Blood Advances|2024Cited by 1
Utilization of Autologous HCT in Multiple Myeloma: A Novel Linkage of CIBMTR, Cancer Registry and Hospitalization Data in CaliforniaNaseem Esteghamat, Theresa H.M. Keegan, Ann Brunson et al.|Blood|2022Cited by 0